Glass House Brands (GLAS) Accumulated Expenses (2022 - 2025)
Glass House Brands' (GLAS) quarterly Accumulated Expenses came in at $17.9 million in Q4 2025, up 24.46% year-on-year from $14.4 million in Q4 2024, and up 24.46% on a QoQ basis from $14.4 million in Q4 2024.
Glass House Brands (GLAS) Accumulated Expenses (2022 - 2025) Analysis & Trends
Glass House Brands (GLAS) has 4 years of Accumulated Expenses data on file, last reported at $17.9 million in Q4 2025.
- On a quarterly basis, Accumulated Expenses rose 24.46% year-over-year to $17.9 million in Q4 2025; TTM through Dec 2025 was $17.9 million, a 24.46% increase from a year earlier, with the FY2025 full-year figure at $17.9 million, up 24.46% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $17.9 million, up from $14.4 million in the prior quarter.
- Over the last five years, Accumulated Expenses for GLAS reached as high as $17.9 million in Q4 2025 and fell as low as $1.2 million in Q1 2022.
- Historically, Accumulated Expenses has averaged $11.7 million across 4 years, with a median of $13.8 million in 2023.
- Across the five-year window, Accumulated Expenses grew 9.8% in 2024 and climbed 24.46% in 2025, its largest moves.
- Year by year, Accumulated Expenses stood at $1.2 million in 2022, then soared by 995.41% to $13.1 million in 2023, then gained by 9.8% to $14.4 million in 2024, then increased by 24.46% to $17.9 million in 2025.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $17.9 million in Q4 2025, $14.4 million in Q4 2024, and $13.1 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.93 Mn |
| Dec 31, 2024 | 14.41 Mn |
| Dec 31, 2023 | 13.12 Mn |
| Mar 31, 2022 | 1.20 Mn |